BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 18562269)

  • 1. Biomarker selection and sample prediction for multi-category disease on MALDI-TOF data.
    Oh JH; Kim YB; Gurnani P; Rosenblatt KP; Gao JX
    Bioinformatics; 2008 Aug; 24(16):1812-8. PubMed ID: 18562269
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Peak selection from MALDI-TOF mass spectra using ant colony optimization.
    Ressom HW; Varghese RS; Drake SK; Hortin GL; Abdel-Hamid M; Loffredo CA; Goldman R
    Bioinformatics; 2007 Mar; 23(5):619-26. PubMed ID: 17237065
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identifying serological biomarkers of hepatocellular carcinoma using surface-enhanced laser desorption/ionization-time-of-flight mass spectroscopy.
    Wu FX; Wang Q; Zhang ZM; Huang S; Yuan WP; Liu JY; Ban KC; Zhao YN
    Cancer Lett; 2009 Jul; 279(2):163-70. PubMed ID: 19268439
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Surface enhanced laser desorption/ionization profiling: New diagnostic method of HBV-related hepatocellular carcinoma.
    Wu C; Wang Z; Liu L; Zhao P; Wang W; Yao D; Shi B; Lu J; Liao P; Yang Y; Zhu L
    J Gastroenterol Hepatol; 2009 Jan; 24(1):55-62. PubMed ID: 18823443
    [TBL] [Abstract][Full Text] [Related]  

  • 5. SELDI-TOF MS proteinchip technology for screening of serum markers of HBV-induced hepatocellular carcinoma.
    Geng X; Wang F; Li YG; Zhu GP; Zhang WM
    J Exp Clin Cancer Res; 2007 Dec; 26(4):505-8. PubMed ID: 18365545
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Analysis of mass spectral serum profiles for biomarker selection.
    Ressom HW; Varghese RS; Abdel-Hamid M; Eissa SA; Saha D; Goldman L; Petricoin EF; Conrads TP; Veenstra TD; Loffredo CA; Goldman R
    Bioinformatics; 2005 Nov; 21(21):4039-45. PubMed ID: 16159919
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prostate cancer biomarker discovery using high performance mass spectral serum profiling.
    Oh JH; Lotan Y; Gurnani P; Rosenblatt KP; Gao J
    Comput Methods Programs Biomed; 2009 Oct; 96(1):33-41. PubMed ID: 19423179
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Quantitative quality-assessment techniques to compare fractionation and depletion methods in SELDI-TOF mass spectrometry experiments.
    Harezlak J; Wang M; Christiani D; Lin X
    Bioinformatics; 2007 Sep; 23(18):2441-8. PubMed ID: 17626063
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An extended Markov blanket approach to proteomic biomarker detection from high-resolution mass spectrometry data.
    Oh JH; Gurnani P; Schorge J; Rosenblatt KP; Gao JX
    IEEE Trans Inf Technol Biomed; 2009 Mar; 13(2):195-206. PubMed ID: 19126475
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Proteomic data analysis workflow for discovery of candidate biomarker peaks predictive of clinical outcome for patients with acute myeloid leukemia.
    Forshed J; Pernemalm M; Tan CS; Lindberg M; Kanter L; Pawitan Y; Lewensohn R; Stenke L; Lehtiö J
    J Proteome Res; 2008 Jun; 7(6):2332-41. PubMed ID: 18452325
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Independent component analysis for the extraction of reliable protein signal profiles from MALDI-TOF mass spectra.
    Mantini D; Petrucci F; Del Boccio P; Pieragostino D; Di Nicola M; Lugaresi A; Federici G; Sacchetta P; Di Ilio C; Urbani A
    Bioinformatics; 2008 Jan; 24(1):63-70. PubMed ID: 18003646
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Imaging mass spectrometry provides fingerprints for distinguishing hepatocellular carcinoma from cirrhosis.
    Le Faouder J; Laouirem S; Chapelle M; Albuquerque M; Belghiti J; Degos F; Paradis V; Camadro JM; Bedossa P
    J Proteome Res; 2011 Aug; 10(8):3755-65. PubMed ID: 21675781
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Discrimination of Penicillium isolates by matrix-assisted laser desorption/ionization time-of-flight mass spectrometry fingerprinting.
    Hettick JM; Green BJ; Buskirk AD; Kashon ML; Slaven JE; Janotka E; Blachere FM; Schmechel D; Beezhold DH
    Rapid Commun Mass Spectrom; 2008 Aug; 22(16):2555-60. PubMed ID: 18646251
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serum peptidome profiling revealed platelet factor 4 as a potential discriminating Peptide associated with pancreatic cancer.
    Fiedler GM; Leichtle AB; Kase J; Baumann S; Ceglarek U; Felix K; Conrad T; Witzigmann H; Weimann A; Schütte C; Hauss J; Büchler M; Thiery J
    Clin Cancer Res; 2009 Jun; 15(11):3812-9. PubMed ID: 19470732
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Selective deposition of agrin in the microvasculature of hepatocellular carcinoma: aspects in pathogenesis and differential diagnosis].
    Tátrai P
    Magy Onkol; 2008 Dec; 52(4):379-83. PubMed ID: 19068466
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ovarian cancer identification based on dimensionality reduction for high-throughput mass spectrometry data.
    Yu JS; Ongarello S; Fiedler R; Chen XW; Toffolo G; Cobelli C; Trajanoski Z
    Bioinformatics; 2005 May; 21(10):2200-9. PubMed ID: 15784749
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Histology-directed matrix-assisted laser desorption/ionization analysis reveals tissue origin and p53 status of primary liver cancers.
    Jeon YE; Lee SC; Paik SS; Lee KG; Jin SY; Kim HR; Yoo CW; Park HM; Han SY; Choi DH; Kim HK
    Pathol Int; 2011 Aug; 61(8):449-55. PubMed ID: 21790858
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fecal metabolome profiling of liver cirrhosis and hepatocellular carcinoma patients by ultra performance liquid chromatography-mass spectrometry.
    Cao H; Huang H; Xu W; Chen D; Yu J; Li J; Li L
    Anal Chim Acta; 2011 Apr; 691(1-2):68-75. PubMed ID: 21458633
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Specific MALDI imaging and profiling for biomarker hunting and validation: fragment of the 11S proteasome activator complex, Reg alpha fragment, is a new potential ovary cancer biomarker.
    Lemaire R; Menguellet SA; Stauber J; Marchaudon V; Lucot JP; Collinet P; Farine MO; Vinatier D; Day R; Ducoroy P; Salzet M; Fournier I
    J Proteome Res; 2007 Nov; 6(11):4127-34. PubMed ID: 17939699
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Enrichment of low molecular weight fraction of serum for MS analysis of peptides associated with hepatocellular carcinoma.
    Orvisky E; Drake SK; Martin BM; Abdel-Hamid M; Ressom HW; Varghese RS; An Y; Saha D; Hortin GL; Loffredo CA; Goldman R
    Proteomics; 2006 May; 6(9):2895-902. PubMed ID: 16586431
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.